We are live on ! Find out more
BHG

Blue Harbour Group Portfolio holdings

AUM $353M
1-Year Est. Return 8.9%
This Fund
S&P 500
This Quarter Est. Return
-1.23%
1 Year Est. Return
-8.9%
3 Year Est. Return
-5.15%
5 Year Est. Return
+14.39%
10 Year Est. Return
–
AUM
$2.6B
AUM Growth
-$180M
Cap. Flow
-$107M
Cap. Flow %
-4.11%
Top 10 Hldgs %
75.3%
Holding
20
New
4
Increased
5
Reduced
6
Closed
1
Avg Time Held
5.4 quarters
Top 10 Avg Time Held
4.7 quarters
Top 20 Avg Time Held
5.4 quarters

Top Sells

Rank Stock Value
1
AKAM icon
Akamai
AKAM
+$170M
2
BWXT icon
BWX Technologies
BWXT
+$160M
3
AGCO icon
AGCO
AGCO
+$130M
4
AVT icon
Avnet
AVT
+$120M
5
XLNX
Xilinx Inc
XLNX
+$66M

Sector Composition

Rank Sector Weight
1 Technology 30.43%
2 Healthcare 20.2%
3 Financials 18.54%
4 Consumer Discretionary 8.61%
5 Industrials 8.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
ISBC
1
DELISTED
Investors Bancorp, Inc.
ISBC
$395M 15.23%
29,582,428
– –
2014 Q1
13 quarters
XLNX
2
DELISTED
Xilinx Inc
XLNX
$322M 12.42%
5,013,093
-1,045,600
-17% -$66M
2015 Q1
9 quarters
ADNT icon
3
Adient
ADNT
$1.39B
$223M 8.61%
3,416,390
+1,740,820
+104% +$118M
2017 Q1
1 quarter
OTEX icon
4
Open Text
OTEX
$6.04B
$220M 8.49%
6,989,270
+3,969,301
+131% +$131M
2017 Q1
1 quarter
WBMD
5
DELISTED
WebMD Health Corp.
WBMD
$197M 7.6%
3,361,336
– –
2016 Q4
2 quarters
FFIV icon
6
F5
FFIV
$27B
$128M 4.94%
1,009,416
+71,066
+8% +$9.31M
2016 Q1
5 quarters
AGCO icon
7
AGCO
AGCO
$7.53B
$119M 4.6%
1,771,048
-2,042,652
-54% -$130M
2014 Q2
12 quarters
MDRX
8
DELISTED
Veradigm Inc. Common Stock
MDRX
$119M 4.58%
9,309,695
– –
2013 Q2
16 quarters
SYNH
9
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$116M 4.46%
+1,976,722
New +$103M
2017 Q2
0 quarters
RDC
10
DELISTED
Rowan Companies Plc
RDC
$113M 4.37%
11,078,412
+535,600
+5% +$7.02M
2014 Q1
13 quarters
IWM icon
11
iShares Russell 2000 ETF
IWM
$77.9B
$100M 3.87%
712,500
-22,090
-3% -$3.06M
2016 Q4
2 quarters
BWXT icon
12
BWX Technologies
BWXT
$12.7B
$97.2M 3.74%
1,992,829
-3,295,098
-62% -$160M
2013 Q4
14 quarters
MD icon
13
Pediatrix Medical
MD
$2.16B
$92.7M 3.57%
1,536,079
– –
2016 Q3
3 quarters
AXTA icon
14
Axalta
AXTA
$7.18B
$89.9M 3.47%
+2,806,692
New +$89.6M
2017 Q2
0 quarters
LAZ icon
15
Lazard
LAZ
$3.56B
$67.1M 2.59%
1,448,815
-271,226
-16% -$12.2M
2016 Q4
2 quarters
VISN icon
16
Vistance Networks Inc
VISN
$1.41B
$66.6M 2.56%
+1,750,000
New +$67.6M
2017 Q2
0 quarters
SPY icon
17
State Street SPDR S&P 500 ETF Trust
SPY
$822B
$56.5M 2.18%
233,700
+48,100
+26% +$11.5M
2016 Q4
2 quarters
AVT icon
18
Avnet
AVT
$8.19B
$51.9M 2%
1,335,450
-3,028,424
-69% -$120M
2015 Q2
8 quarters
DBRG icon
19
DELISTED
DigitalBridge
DBRG
$18.8M 0.72%
+333,042
New +$18.1M
2017 Q2
0 quarters
AKAM icon
20
Akamai
AKAM
$14.4B
– –
-2,855,493
Closed -$170M –

Similar funds

Blue Harbour Group's Q2 2017 Portfolio in Review

As of Q2 2017, Blue Harbour Group held 20 positions worth $2.6B, down 6.5% from $2.78B the previous quarter. Its ten largest holdings account for 75% of the portfolio.

Blue Harbour Group withdrew a net $107M in Q2 2017, closing 1 position and reducing 6 holdings. Its most notable exit was Akamai, an estimated $170M position sold in full.

By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 34% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Blue Harbour Group opened a new position in Syneos Health, Inc. Class A Common Stock worth $116M.

  • Blue Harbour Group's largest Q2 2017 buy was Syneos Health, Inc. Class A Common Stock: 1,976,722 shares worth $116M.
  • Blue Harbour Group added most to Open Text in Q2 2017, an estimated $131M increase.
  • Blue Harbour Group's biggest Q2 2017 reduction was BWX Technologies, cutting an estimated $160M.
  • Blue Harbour Group fully exited Akamai in Q2 2017, selling an estimated $170M.
  • Blue Harbour Group's ten largest holdings make up 75% of its $2.6B portfolio in Q2 2017.
  • Blue Harbour Group opened 4 new positions and closed 1 in Q2 2017.
  • Blue Harbour Group's portfolio value fell 6.5% quarter-over-quarter to $2.6B.

Based on Blue Harbour Group's 13F filing for Q2 2017, filed 14 Aug 2017.